The data from 2019 to 2023 show rapid uptake of the drugs alongside wide patient- and practice-level variations.

Though most models aren’t ready for prime time, AI is expected to have a “tremendous” impact on practice in the coming years.

This month: good news for java lovers, a how-to guide on migraine and CVD, medically tailored meals for HF, and more.

Declines in moderate-to-vigorous exercise start in midlife, then speed up before diagnosis—raising opportunities to intervene ...

The “hypothesis-generating” results show that the technology might improve use of preventive therapies, especially in women.

Despite an increase in the conversion factor, slashed payments elsewhere could amount to “death by a thousand paper cuts.” ...

The study isn’t intended to sway clinical decision-making, but to make doctors aware of the impact of their choices.

Half of male cyclists had some myocardial scarring, but experts caution against taking this to mean too much exercise is ...

The predicted risks didn’t align well with actual events, raising questions about how well the tool will fare if rolled out.

The technology, which led to a shift in strategy more than half of the time, could save $719 per symptomatic patient over 10 years.

Patients whose hypertension diagnosis is delayed are less likely to get the drugs they need and face higher CV risks over the ...

Does colchicine work for CVD or doesn’t it? That’s the question the study authors hoped to answer, but there’s little ...